Endogenously produced IL-8 acts in an autocrine manner to increase the growth of nasopharyngeal tumor spheres and human melanoma cells [10, 11] and also participates in the regulation of patient-derived breast cancer stem cell activity [12]. This evidence concerns the gene CXCL8 and breast cancer.